about
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to ad...
Read More
10.01
-0.03
(-0.30%)
23,593
XNAS Volume
XNAS 11 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
LeonaBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..